Conduct comprehensive neuropsychological testing across multiple cognitive domains.
Management
Monitor patients with cortical microinfarcts closely for progressive brain atrophy and cognitive decline.
Consider integrated approaches addressing both vascular and neurodegenerative contributions to cognitive impairment.
Monitoring & Follow-up
Longitudinal neuroimaging to track brain volume changes over time.
Repeated neuropsychological assessments to evaluate cognitive trajectories, especially in executive function, memory, language, and visuospatial domains.
Risks
Increased number of cortical microinfarcts elevates risk of accelerated brain atrophy and dementia progression.
Combined presence of microinfarcts and brain atrophy leads to greater cognitive deterioration than either pathology alone.
Patient & Prescribing Data
Older adults with cognitive impairment or dementia undergoing memory clinic evaluation
No direct treatment data provided; findings emphasize importance of early detection and monitoring of microinfarcts and brain atrophy to inform prognosis and potential interventions.
Clinical Best Practices
Incorporate high-resolution MRI protocols to identify cortical microinfarcts in patients with cognitive complaints.
Use quantitative brain volume analysis tools for objective assessment of atrophy progression.
Evaluate multiple cognitive domains longitudinally to detect subtle declines linked to microinfarcts and atrophy.
Recognize the synergistic impact of mixed pathologies on cognition to guide comprehensive patient management.
